Boston Scientific says Penumbra close will push into Q1 2027
By Curtis Eichelberger ( October 28, 2026, 15:23 GMT | Insight) -- Boston Scientific Chief Executive Officer Mike Mahoney said the company expects to close the acquisition of Penumbra in the first quarter of 2027. “The regulatory process has taken a bit of time,” Mahoney said on the company's Q3 earnings call. “We're still very confident in closing the transaction, but based on some of the discussions with the regulatory authorities, we anticipate a early first quarter close.”Boston Scientific Chief Executive Officer Mike Mahoney said the company expects to close the acquisition of Penumbra in the first quarter of 2027. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.